Trans-1-[(Tert-Butoxy)Carbonyl]-4-Hydroxypyrrolidine-2-Carboxylic Acid

In solid-phase peptide synthesis governed by Fmoc/tBu strategy, the trans-4-hydroxyproline scaffold bearing N-Boc protection serves as a conformationally restricted building block whose ring pucker directly influences the ψ and φ dihedral angles of the growing peptide backbone. The compound is typically introduced at 1.1 to 1.5 molar equivalents relative to resin loading (commonly 0.4–0.8 mmol/g on aminomethyl polystyrene), activated with HATU or PyBOP in the presence of 0.2 M N-methylmorpholine in DMF. Coupling completion is verified via Kaiser test or chloranil test; negative result triggers a brief 15-minute double-coupling cycle with fresh activated species when the sterically encumbered secondary amine of the pyrrolidine ring displays sluggish acylation kinetics. The free 4-hydroxyl group remains available for on-resin phosphorylation with dibenzyl N,N-diisopropylphosphoramidite and 0.45 M tetrazole in acetonitrile, or for sulfation with SO₃·pyridine complex in anhydrous pyridine at 40°C, generating post-translational modification mimics without requiring a separate orthogonal protecting group removal step.

When Does Epimerization at C2 Become Detectable During Fragment Condensation in Solution-Phase Syntheses?

Solution-phase segment condensation employing this building block demands strict temperature control. Activation of the C2 carboxylic acid via mixed anhydride method using isobutyl chloroformate and N-methylmorpholine in THF at −15 ± 3°C minimizes oxazolone formation and the consequent racemization at the α-carbon. Monitoring by chiral HPLC (Chiralpak IA column, 90:10 hexane/isopropanol, 1.0 mL/min) reveals that epimerized D-allo diastereomer remains below 0.3 area% when the pre-activation time does not exceed 90 seconds. If the temperature rises above −5°C during slow addition of the nucleophilic amine component—particularly with poorly nucleophilic anilines requiring extended reaction times—the D-epimer can accumulate to 2.5–4.0%, necessitating a subsequent trituration from diethyl ether/n-heptane to restore diastereomeric purity above 99.5%. The Boc group remains intact throughout these manipulations provided the pH of any aqueous workup is maintained between 4.5 and 7.0; exposure to pH <2 for durations exceeding 30 minutes leads to measurable tert-butyl cation liberation and pyrrolidine ring N-deprotection detectable by ¹H NMR disappearance of the singlet at 1.42 ppm.

Conformational Locking of Macrocyclic Peptide Scaffolds via Proline-Derived Turn Inducers

Macrocyclic peptides in the 600–1200 Da range often suffer from conformational heterogeneity that blunts target binding affinity and metabolic stability. Insertion of trans-4-hydroxyproline residues derived from this Boc-protected intermediate at the i+1 position of a β-turn motif enforces an exo ring pucker (χ₁ ≈ −20° to −35°, measured by ³J_Hα-Hβ coupling constants in DMSO-d₆) that pre-organizes the backbone for cyclization. In a representative 14-membered cyclic peptide synthesis on 2-chlorotrityl chloride resin, loading the hydroxyproline building block via its side-chain hydroxyl onto the resin at 0.2 mmol/g (achieved by treating the resin with 2.0 eq. of the compound and 4.0 eq. of DIPEA in DCM for 16 hours) positions the C-terminal carboxylate for subsequent head-to-tail macrolactamization. Cyclization yields, monitored by analytical RP-HPLC at 214 nm, improve from a baseline of 42% (for a glycine-containing linear precursor using HATU/HOAt in 1 mM pseudo-dilution conditions) to 73% when the pyrrolidine ring pre-organizes the N- and C-termini into proximity. The Boc group is cleaved with 50% TFA in DCM containing 2.5% triisopropylsilane over 45 minutes, liberating the pyrrolidine nitrogen for further functionalization without detectable cleavage of the ester linkage at the 4-position when monitored by LC-MS total ion current.

On kilogram-scale campaigns for integrin-binding cyclic pentapeptides, the compound is charged into a jacketed 50 L reactor as a 0.6 M stock in anhydrous DMF pre-dried over 3Å molecular sieves to water content below 50 ppm (Karl Fischer titration). The exothermicity of HBTU-mediated activation (ΔT ≈ 8–12°C over 10 minutes in a 20 L batch) requires a recirculating chiller set to 0°C. Agitation at 180–220 RPM with a pitched-blade impeller ensures homogeneity without vortex entrainment of atmospheric moisture. The crude cyclic peptide, after TFA-mediated global deprotection and precipitation from cold methyl tert-butyl ether, exhibits a product-related impurity profile where the des-hydroxyproline analog (arising from incomplete incorporation of this building block or β-elimination during TFA treatment at temperatures above 25°C) must be controlled to NMT 0.10% per ICH Q3A guidelines for a daily dose of ≤2 g.

How the 4-Hydroxyl Substituent Alters Pharmacokinetic Clearance When the Fragment Is Retained in the Active Pharmaceutical Ingredient

When this trans-4-hydroxyproline derivative is not used as a transient chiral auxiliary but remains embedded in the final drug substance—exemplified by certain hepatitis C virus NS3/4A protease inhibitors—the free hydroxyl group introduces a metabolic soft spot and a handle for glucuronidation. In vitro microsomal stability assays in pooled human liver microsomes (HLM, 0.5 mg/mL protein concentration, NADPH-regenerating system) reveal that the parent compound with free 4-OH exhibits an intrinsic clearance (Cl_int) of 48 μL/min/mg, whereas the corresponding 4-O-methyl ether analog shows Cl_int of 12 μL/min/mg. This 4-fold difference, attributed to UGT1A1-mediated O-glucuronidation confirmed by incubation with recombinant UGT isoforms, directs formulation scientists toward either prodrug strategies (phosphonooxymethyl or acyloxymethyl capping of the 4-OH) or co-formulation with a UGT inhibitor if high first-pass extraction must be mitigated. The Boc group itself is absent from the final API; its removal during the penultimate synthetic step using HCl in dioxane (4.0 M, 2 hours, 20°C) generates the hydrochloride salt of the pyrrolidine nitrogen, which is then coupled to the P2 quinoline acid fragment using EDCI·HCl and HOAt in DMF at 0.12 M.

Residual Boc-protected intermediate in the final drug substance, arising from incomplete deprotection, constitutes a process-related impurity controlled to a limit of ≤0.15% (ICH Q3A threshold for a 2 g/day dose) and is quantified by a dedicated UPLC method using a C18 column (1.7 μm, 2.1 × 50 mm) with 0.1% trifluoroacetic acid in water/acetonitrile gradient, UV detection at 205 nm, and a quantitation limit of 0.01 μg/mL corresponding to 0.02% relative to a 0.5 mg/mL sample concentration. Cross-validation against ¹³C NMR spectroscopy (150 MHz, CD₃OD) targeting the quaternary tert-butyl carbon resonance at 28.5 ppm provides orthogonal confirmation when HPLC results fall between 0.10% and 0.20%, which is recognized as the region of highest measurement uncertainty.

N-Boc-cis-4-Hydroxy-D-Proline Methyl Ester

A stoichiometric inversion of the trans configuration at C4 is achievable via a Mitsunobu protocol that retains the Boc group at N1 and the carboxyl oxidation state at C2. The trans-hydroxy starting material is dissolved in anhydrous THF (0.25 M) and treated with 1.2 eq. of triphenylphosphine, 1.2 eq. of diisopropyl azodicarboxylate (DIAD), and 1.5 eq. of p-nitrobenzoic acid at −10°C to 0°C. After 18 hours at ambient temperature, the resulting p-nitrobenzoate ester is saponified with 1.0 M LiOH in 3:1 THF/water at 5°C to liberate the cis-4-hydroxy compound. The inversion is confirmed by the change in the ¹H NMR coupling pattern of the C4 methine proton: the trans isomer displays a ddd with ³J_H3α-H4 = 4.2 Hz and ³J_H3β-H4 = 1.8 Hz, while the cis isomer exhibits a pseudo-quartet with 3.8 Hz splitting to both vicinal protons. This cis-configured building block provides access to peptide sequences where the hydroxyl group engages in intramolecular hydrogen bonding to a backbone carbonyl, stabilizing a γ-turn conformation as evidenced by the temperature coefficient of the amide proton chemical shift (Δδ/ΔT) measuring −2.1 ppb/K versus −5.8 ppb/K for the solvent-exposed trans analog in DMSO-d₆.

Activation for Chemoselective Ligation at the 4-Position Without Disturbing the N-Boc Carbamate

The 4-hydroxyl group can be converted to a leaving group for subsequent nucleophilic displacement or metal-catalyzed cross-coupling, provided the Boc group remains intact. Mesylation with methanesulfonyl chloride (1.05 eq.) and triethylamine (1.2 eq.) in DCM at 0–5°C proceeds within 45 minutes, generating the 4-O-mesyl derivative as a white crystalline solid after aqueous workup and n-heptane trituration. The mesylate serves as an electrophile for S_N2 displacement with sodium azide in DMF at 60°C, inverting the C4 configuration to afford the cis-4-azido compound—a precursor to triazole-containing peptidomimetics via Cu(I)-catalyzed azide-alkyne cycloaddition using 0.05 eq. CuSO₄·5H₂O and 0.10 eq. sodium ascorbate in 1:1 t-BuOH/water. The Boc group tolerates these conditions; azide reduction to the corresponding amine with 10% Pd/C under 1 atm H₂ in ethanol, however, must be monitored for competing hydrogenolytic cleavage of the N-Boc group, which becomes significant (>5% after 4 hours) if the catalyst loading exceeds 20 wt% or if the hydrogen pressure is raised above 3 bar. The liberated 4-amino group can be acylated with Fmoc-protected amino acid chlorides or coupled to biotin-OSu esters for affinity probe construction, with the Boc group removed cleanly in a subsequent orthogonal deprotection step using 20% TFA/DCM.

Oxidation of the 4-hydroxyl to the corresponding ketone using Dess-Martin periodinane (1.1 eq.) in DCM at ambient temperature (2 hours) yields N-Boc-4-oxopyrrolidine-2-carboxylic acid, a versatile electrophile for reductive amination with primary amines and NaBH(OAc)₃ in 1,2-dichloroethane. This ketone intermediate, however, is susceptible to β-elimination of the Boc carbamate under mildly basic conditions (pH >8.5), generating the α,β-unsaturated pyrroline species detectable by the appearance of a vinyl proton signal at 6.85 ppm (¹H NMR, CDCl₃). To suppress this pathway, reductive amination is conducted with 1.5 eq. of amine and 1.4 eq. of NaBH(OAc)₃ in the presence of 1.0 eq. of acetic acid as a buffering agent, maintaining the reaction pH near 5.5–6.0. Under these optimized conditions, the elimination byproduct is held below 2.0 area% by HPLC.